Microbiotica Revenue and Competitors
Estimated Revenue & Valuation
- Microbiotica's estimated annual revenue is currently $11M per year.
- Microbiotica's estimated revenue per employee is $155,000
Employee Data
- Microbiotica has 71 Employees.
- Microbiotica grew their employee count by 16% last year.
Microbiotica's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | SVP Research | Reveal Email/Phone |
3 | VP Program and Alliance Management | Reveal Email/Phone |
4 | VP Pre-Clinical Development | Reveal Email/Phone |
5 | VP Operations and Company Secretary | Reveal Email/Phone |
6 | Chief Business Officer | Reveal Email/Phone |
7 | Director, Translational Biology (in vivo) | Reveal Email/Phone |
8 | Director | Reveal Email/Phone |
9 | Senior Director, Informatics | Reveal Email/Phone |
10 | Associate Director, Bioinformatics | Reveal Email/Phone |
Microbiotica Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.5M | 29 | -12% | N/A | N/A |
#2 | $15.7M | 101 | 5% | N/A | N/A |
#3 | $87.9M | 405 | 25% | $292M | N/A |
#4 | $2.6M | 470 | 16% | $631.7M | N/A |
#5 | $14.9M | 96 | -8% | $81M | N/A |
#6 | $44.8M | 231 | 0% | $132.9M | N/A |
#7 | $7.6M | 49 | -37% | N/A | N/A |
#8 | $17.4M | 112 | 12% | N/A | N/A |
#9 | $334.6M | 1349 | 11% | £994.6M | N/A |
#10 | $830.2M | 5356 | 8% | N/A | N/A |
What Is Microbiotica?
Microbiotica is transforming personalised medicine with leading microbiome science, identifying gut bacteria linked to patient phenotype with unprecedented precision for the discovery of novel microbiome-based medicines and biomarkers of drug response. Microbiotica was spun out of Trevor Lawley's Lab at the Wellcome Sanger Institute and is founded on a unique pipeline for culturing and genomically characterising the entirety of the bacteria in the human gut for the first time. It has the world's largest microbiome genome database and culture collection, a suite of translational in vitro and animal models, and state of the art bioinformatics and AI. The company has a focus on IBD and Immuno-Oncology, and a program in C. difficile which is spearheading innovation in development of live bacterial products.
keywords:N/A
N/A
Total Funding
71
Number of Employees
$11M
Revenue (est)
16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Microbiotica News
Microbiotica Ltd. of Cambridge, U.K., has raised £50 million ($67 million) in series B funding as the company aims to test its...
Microbiotica, a Cambridge, UK-based player in discovering and developing microbiome-based therapeutics and biomarkers, closed a £50m ($67m)...
Microbiotica is a leading player in the field of microbiome-based therapeutics, biomarkers and targets. The Company is building a growing...
Microbiotica’s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology 24-06-2021 Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, today announces that its Live Bacterial Therapeutic (LBT) MB097 is now in pre-clinical ...
Microbiotica’s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology 24-06-2021 Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, today announces that its Live Bacterial Therapeutic (LBT) MB097 is now in pre-clinical ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.3M | 71 | 9% | N/A |
#2 | $15.7M | 71 | 6% | N/A |
#3 | $11.2M | 72 | -43% | N/A |
#4 | $9.1M | 72 | -21% | N/A |
#5 | $11.2M | 72 | 3% | N/A |